Evidence map›Paper›PMID 26887924›Full record

ArticleNature communications2016

Differential Rac1 signalling by guanine nucleotide exchange factors implicates FLII in regulating Rac1-driven cell migration.

Hadir Marei, Alejandro Carpy, Anna Woroniuk, Claire Vennin, Gavin White, Paul Timpson, Boris Macek, Angeliki Malliri

Open access · goldAbstract read
In one paragraph

Article in Nature communications, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 52 papers.

0numbers the graph read from it
0cells of the map it votes in
52citing papers in PubMed
6.4field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

52 citing papers in PubMed, 84 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
  4. Article
  5. Article
  6. NIBAN2/FLII/RREB1 Axis Drives Glioma Stem Cell Malignancy via TLR3 Pathway Activation.Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2026
    Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Review
  12. mSphere · 2024
    Article
  13. Article
  14. Article
  15. Intrinsic epigenetic state of primary osteosarcoma drives metastasis.bioRxiv : the preprint server for biology · 2023
    Article
  16. A TIAM1-TRIM28 complex mediates epigenetic silencing of protocadherins to promote migration of lung cancer cells.Proceedings of the National Academy of Sciences of the United States of America · 2023
    Article
  17. A human FLII gene variant alters sarcomeric actin thin filament length and predisposes to cardiomyopathy.Proceedings of the National Academy of Sciences of the United States of America · 2023
    Article
  18. Article
  19. PUFA-DerivedACS chemical biology · 2022
    Article
  20. Wound Healing from an Actin Cytoskeletal Perspective.Cold Spring Harbor perspectives in biology · 2022
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 4 institutions in 3 countries.

Hadir MareiCell Signalling Group, Cancer Research UK Manchester Institute, The University of Manchester, Manchester M204BX, UK.
Alejandro CarpyProteome Center Tuebingen, Interfaculty Institute for Cell Biology, University of Tuebingen, Tuebingen 72026, Germany.
Anna WoroniukCell Signalling Group, Cancer Research UK Manchester Institute, The University of Manchester, Manchester M204BX, UK.
Claire VenninInvasion and Metastasis Group, Garvan Institute of Medical Research, The Kinghorn Cancer Centre, Faculty of Medicine, St Vincent's Clinical School, University of New South Wales, Darlinghurst, New South Wales 2010, Australia.
Gavin WhiteCell Signalling Group, Cancer Research UK Manchester Institute, The University of Manchester, Manchester M204BX, UK.
Paul TimpsonInvasion and Metastasis Group, Garvan Institute of Medical Research, The Kinghorn Cancer Centre, Faculty of Medicine, St Vincent's Clinical School, University of New South Wales, Darlinghurst, New South Wales 2010, Australia.
Boris MacekProteome Center Tuebingen, Interfaculty Institute for Cell Biology, University of Tuebingen, Tuebingen 72026, Germany.
Angeliki MalliriCell Signalling Group, Cancer Research UK Manchester Institute, The University of Manchester, Manchester M204BX, UK.
Cancer Research UK Manchester Institute · GBUniversity of Tübingen · DEGarvan Institute of Medical Research · AUThe Kinghorn Cancer Centre · AU

Funding

Cancer Research UK 20410Cancer Research UK C5759/A12328
6 · The paper itself

Abstract

The small GTPase Rac1 has been implicated in the formation and dissemination of tumours. Upon activation by guanine nucleotide exchange factors (GEFs), Rac1 associates with a variety of proteins in the cell thereby regulating various functions, including cell migration. However, activation of Rac1 can lead to opposing migratory phenotypes raising the possibility of exacerbating tumour progression when targeting Rac1 in a clinical setting. This calls for the identification of factors that influence Rac1-driven cell motility. Here we show that Tiam1 and P-Rex1, two Rac GEFs, promote Rac1 anti- and pro-migratory signalling cascades, respectively, through regulating the Rac1 interactome. In particular, we demonstrate that P-Rex1 stimulates migration through enhancing the interaction between Rac1 and the actin-remodelling protein flightless-1 homologue, to modulate cell contraction in a RhoA-ROCK-independent manner.

Indexed as

Cell MovementSignal TransductionActinsAnimalsCarrier ProteinsCell LineGuanine Nucleotide Exchange FactorsHumansMiceMicrofilament Proteinsrac1 GTP-Binding ProteinT-Lymphoma Invasion and Metastasis-inducing Protein 1Trans-ActivatorsActinsCarrier ProteinsFlII protein, mouseGuanine Nucleotide Exchange FactorsMicrofilament ProteinsPREX1 protein, mouserac1 GTP-Binding ProteinTiam1 protein, mouseT-Lymphoma Invasion and Metastasis-inducing Protein 1Trans-Activators

Identifiers

PMID26887924
PMCPMC4759627
OpenAlexW2289000286

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.